Wearable tag aims to spot heart failure patients at risk of returning to hospital

NCT ID NCT04550052

Terminated Knowledge-focused Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether a small wearable sensor called the Spire Health Tag could reliably track heart rate, activity, sleep, and stress in heart failure patients after they leave the hospital. The goal was to see if the device could capture useful data for at least 80% of the time over 30 days. The study was terminated early and enrolled only 36 participants, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Spire Health Tag (wearable sensor)
What this could lead to: If successful, this approach could help doctors identify heart failure patients at risk of returning to the hospital, enabling earlier interventions.
What could go wrong: This was a small pilot study that was terminated early, so results are limited. The device may not reliably capture data in all patients or predict readmissions accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

University of Rochester

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.